Profile of proinflammatory cytokines in children with Mycoplasma pneumoniae pneumonia
暂无分享,去创建一个
Zhengrong Chen | Chuangli Hao | Li Huang | W. Ji | Yong-dong Yan | Mei-juan Wang | Yuqing Wang | Ge Dai | Ting Wang | C. Zhu | Huiming Sun
[1] Tingting Wang,et al. Corrigendum to "Imbalance of peripheral blood Th17 and Treg responses in children with refractory Mycoplasma pneumoniae pneumonia" [J Infect Chemother 22 (2016) 162-166]. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[2] Zhimin Chen,et al. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children , 2016, Scientific Reports.
[3] K. Izumikawa. Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia , 2016, Front. Microbiol..
[4] J. Simecka,et al. Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses , 2016, PloS one.
[5] Tingting Wang,et al. Imbalance of peripheral blood Th17 and Treg responses in children with refractory Mycoplasma pneumoniae pneumonia. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] Lang Wu,et al. Th1/Th2 Cytokine Profile and Its Diagnostic Value in Mycoplasma pneumoniae Pneumonia , 2016, Iranian journal of pediatrics.
[7] Linding Wang,et al. Decreased Interleukin-10 Responses in Children with Severe Mycoplasma pneumoniae Pneumonia , 2016, PloS one.
[8] Zhengrong Chen,et al. Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia , 2016, PloS one.
[9] R. Chaudhry,et al. Pathogenesis of Mycoplasma pneumoniae: An update , 2016, Indian journal of medical microbiology.
[10] M. Xiao,et al. Epidemiology and clinical features of segmental/lobar pattern Mycoplasma pneumoniae pneumonia: A ten-year retrospective clinical study. , 2015, Experimental and therapeutic medicine.
[11] T. Yamagata,et al. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[12] Zhi-min Chen,et al. Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia , 2015, Pediatric pulmonology.
[13] O. Pakhomova,et al. Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae , 2015, Proceedings of the National Academy of Sciences.
[14] Zhengrong Chen,et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[15] H. Yonezawa,et al. Role of IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae , 2014, BMC Microbiology.
[16] M. Watarai,et al. Cytadherence of Mycoplasma pneumoniae Induces Inflammatory Responses through Autophagy and Toll-Like Receptor 4 , 2014, Infection and Immunity.
[17] A. Gervaix,et al. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland. , 2014, Swiss medical weekly.
[18] N. Miyashita,et al. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[19] K. Yanagihara,et al. Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[20] K. O'Brien,et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries , 2013, Journal of global health.
[21] N. Najafian,et al. The Role of Costimulatory Molecules in Directing the Functional Differentiation of Alloreactive T Helper Cells , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] Jiang-huai Wang,et al. Effects of B7-H3 on the Inflammatory Response and Expression of MMP-9 in Mice with Pneumococcal Meningitis , 2012, Journal of Molecular Neuroscience.
[23] Li Peng,et al. [Levels of interleukin-4 and interferon-gamma in the bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia]. , 2012, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.
[24] S. Blankson,et al. B7-H3 Participates in the Development of Experimental Pneumococcal Meningitis by Augmentation of the Inflammatory Response via a TLR2-Dependent Mechanism , 2012, The Journal of Immunology.
[25] Mingjie Ding,et al. [Th1/Th2 immune response in bronchoalveolar lavage fluid in children with severe Mycoplasma pneumoniae pneumonia]. , 2011, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.
[26] A. Singh,et al. Role of PD‐L1 and PD‐L2 in allergic diseases and asthma , 2011, Allergy.
[27] M. Veldhoen,et al. T helper cell differentiation more than just cytokines. , 2011, Advances in immunology.
[28] Zhimin Chen,et al. Detection of Mycoplasma pneumoniae in different respiratory specimens , 2011, European Journal of Pediatrics.
[29] D. Chaplin,et al. Critical Role of Macrophages and Their Activation via MyD88-NFκB Signaling in Lung Innate Immunity to Mycoplasma pneumoniae , 2010, PloS one.
[30] Yinghui Zhou,et al. B7-H3 Augments the Inflammatory Response and Is Associated with Human Sepsis , 2010, The Journal of Immunology.
[31] J. Stülke,et al. Glycerol Metabolism Is Important for Cytotoxicity of Mycoplasma pneumoniae , 2008, Journal of bacteriology.
[32] Kyung-Yil Lee. Pediatric respiratory infections by Mycoplasma pneumoniae , 2008, Expert review of anti-infective therapy.
[33] Igor Rudan,et al. Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.
[34] D. Burgner,et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children , 2006, Pediatric pulmonology.
[35] K. Waites. New concepts of Mycoplasma pneumoniae infections in children , 2003, Pediatric pulmonology.
[36] R. Martin,et al. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. , 2001, American journal of respiratory cell and molecular biology.
[37] G. Zhu,et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. , 2001, Nature immunology.